Transcutaneous Spinal Electrical Stimulation to Improve Exercise Function After Spinal Cord Injury.

by palligoelme@gmail.com | Jul 9, 2026 | Clinical Trials

​ Conditions: Spinal Cord Injuries (SCI); Spinal Cord Injury; Spinal Injury Interventions: Other: Transcutaneous spinal electrical stimulation (TSES) Sponsors: University of Manitoba Recruiting Conditions: Spinal Cord Injuries (SCI); Spinal Cord Injury; Spinal Injury...

Becotatugvedotin Plus Pucotenlimab in EGFR-Positive Advanced Gastric/GEJ Adenocarcinoma

by palligoelme@gmail.com | Jul 9, 2026 | Clinical Trials

​ Conditions: Gastric Cancer; Gastroesophageal Junction (GEJ) Adenocarcinoma; Becotatug Vedotin; Pucotenlimab Interventions: Drug: Becotatug Vedotin (MRG003); Drug: Pucotenlimab Sponsors: West China Second University Hospital Not yet recruiting Conditions: Gastric...

Morphological and Functional Biomarkers of Skeletal Muscle Adaptations in Sarcopenia

by palligoelme@gmail.com | Jul 9, 2026 | Clinical Trials

​ Conditions: Sarcopenia Interventions: Behavioral: Digitally delivered home-based exercise intervention; Behavioral: General physical activity recommendations Sponsors: I.R.C.C.S Ospedale Galeazzi-Sant’Ambrogio; Universita di Verona Recruiting Conditions:...

Development and Validation of a Colorectal Cancer Diagnostic Model

by palligoelme@gmail.com | Jul 9, 2026 | Clinical Trials

​ Conditions: Colorectal Cancer; Advanced Neoplasia; Prediction Models; Risk Stratification; Precision Screening Sponsors: Peking University Cancer Hospital & Institute; The First Affiliated Hospital of Xiamen University; Fujian Provincial Hospital; People’s...

Multimodal Physiotherapy for Balance and Vertigo in BPPV Patients

by palligoelme@gmail.com | Jul 8, 2026 | Clinical Trials

​ Conditions: Benign Paroxysmal Positional Vertigo; Vertigo; Balance Disorder Interventions: Behavioral: Multimodal Physiotherapy; Procedure: Epley Maneuver Sponsors: Riphah International University Active, not recruiting Conditions: Benign Paroxysmal Positional...

A Real-World Study of Mirvetuximab Soravtansine (MIRV) in Ovarian Cancer Patients of Expression of Folate Receptor α

by palligoelme@gmail.com | Jul 8, 2026 | Clinical Trials

​ Conditions: Ovarian Cancer; Fallopian Tube Cancers; Primary Peritoneal Cancer Interventions: Drug: Mirvetuximab Soravtansine (MIRV) Sponsors: NING LI-GYN Not yet recruiting Conditions: Ovarian Cancer; Fallopian Tube Cancers; Primary Peritoneal Cancer Interventions:...